The table below shows drug alerts, medicines recalls and company-led drug alerts issued in England, Northern Ireland, Scotland and Wales. The information in this table will be updated on an ongoing basis.

Date published



01/7/2020 Drug Recall: Mepacrine hydrochloride tablets 100mg UK
30/6/2020 Drug Alert: Depo-Provera injection 150mg/ml England, Scotland, Northern Ireland
30/6/2020 Medicine supply alert: Fluticasone propionate (Flixotide®) 0.5mg/2ml and 2mg/2ml Nebules Scotland
30/6/2020 Medical drug alert: Philips HeartStart XL Defibrillator/Monitor England
29/6/2020 Medicine supply alert: Prednisolone 5mg Suppositories (RPH Pharmaceuticals) Scotland
29/6/2020 Medicine supply alert: Promazine 25mg and 50mg tablets Scotland
29/6/2020 Medicine supply alert: Phenytoin sodium NRIM 100mg capsules Scotland
19/6/2020 Medicine supply alert: H2-antagonists (cimetidine, famotidine and nizatidine) Scotland
25/06/20 SDA: Nardil® (Phenelzine sulphate) tablets 15mg (25/06/20) England, Northern Ireland, Wales
25/06/20 MSN: Mirtazapine orodispersible tablets 15mg and 45mg UK
25/6/2020 MSN: Alomide® (lodoxamide) eye drops 0.1% England, Northern Ireland, Scotland
25/6/2020 MSN: Imipramine tablets 25mg UK
25/6/2020 MSN: Vimpat® (lacosamide) tablets 50mg England
23/6/2020 CAS alert: risk of heat stress whilst wearing PPE in warn/hot weather England
17/6/2020 Medical device alert: Philips HeartStart MRx Monitor/Defibrillators England
16/6/2020 CAS alert: Dexamethasone approved to treat hospitalised COVID-19 patients UK
9/6/2020 Second update – Early Access to Medicines Scheme for Remdesivir in the treatment of COVID-19. Implementation of the scheme and management of supply UK
8/6/2020 MHRA medical device alert (8/6/20) ISSUED: Results from laboratory-based tests for COVID-19 antibodies using capillary blood sample collection kits may not be reliable (MDA/2020/015) UK
8/6/2020 Drug alert: Epistatus (Midazolam) 10mg/mL Oromucosal Solution (multi Dose Bottle) England
3/6/2020 Update – Early Access to Medicines Scheme for remdesivir in the treatment of COVID-19. Implementation of the scheme and management of supply UK
29/5/2020 SDA: Zyban prolonged release tablets 150mg England
29/5/2020 SDA: Danazol capsules 100mg and 200mg England
28/5/2020 Medicines Defect information: Sodium benzoate sterile solution for injection 2g/10ml England
27/5/2020 Company led recall – Duavive modified release tablets England
26/5/2020 Early Access to Medicines Scheme for remdesivir in the treatment of COVID-19 UK
25/5/2020 SDA: Diamorphine hydrochloride 5mg and 10mg injection  England
22/5/2020 SDA Update- Neuromuscular blocking agents: atracurium, cisatracurium and rocuronium England
18/5/2020 COVID-19 General Case Definition Change UK
18/5/2020 CAS alert: ending the prescribing and supply of antiviral medicines in primary care for the influenza season 2019/20 UK
18/5/2020 Medicines Recall – Emerade injection 500mcg England
13/5/2020 SDA: Salazopyrin suppositories  500mg England
10/5/2020 CAS alert: Tiger Eye Protector Product – removal from the supply chain in respect of COVID-19 use England
7/5/2020 SDA: Phosphate polyfusor 500ml England
5/5/2020 CAS alert: COVID-19 Yellow Card reporting site launched by MHRA UK
6/5/2020 CAS alert: Recruiting patients for clinical trials for COVID-19 therapeutics England
1/5/2020 CAS alert: Message from the UK CMOs and Medical Directors of Public Health England and NHS England England
28/4/2020 SDA: Ativan (lorazepam) 4mg/ml solution for injection England
20/4/2020 Medicines Defect Information – various Glaxosmithkline Consumer Healthcare products England
17/4/2020 CAS alert: Considerations for Personal Protective Equipment in the context of Acute Supply Shortages for Coronavirus Disease 2019 (COVID-19) Pandemic England
16/4/2020 SDA: Neuromuscular blocking agents: atracurium, cisatracurium and rocuronium England
16/4/2020 Medicines Defect Information – levofloxacin tablets 500mg England
14/4/2020 Ibuprofen and coronavirus (COVID-19) UK
10/4/2020 Medical device alert Covid-19: All haemofiltration systems including machines and accessories  England
7/4/2020 Medicines Recall- Emerade solution for injection 300mcg England
3/4/2020 CAS alert: Covid-19: PPE Guidance Update England
30/3/2020 Medicines Defect Information – Paracetamol oral suspension 250mg/5ml England
25/3/2020 Medicines Defect Information: Zamadol SR prolonged-release hard capsules 50mg  England
25/3/2020 SDA: Diamorphine Hydrochloride powder for reconstitution and injection 5mg & 10mg ampoules England
19/3/2020 FMD Medicines information – multiple products England
18/3/2020 Medicines Recall – Esmya tablets 5mg England
11/3/2020 Medicines Defect Information – Aripiprazole 1mg/ml Oral Solution  England
4/3/2020 Medicines Recall – Emerade 150 mcg solution for injection in pre-filled syringe England
27/2/2020 Medicines Defect Information – Oxylan Prolonged-release tablets, all strengths England

Monthly summary of letters and drug alerts that are sent to healthcare professionals and posted on the GOV.UK website

May 2020

April 2020

March 2020

February 2020

January 2020

December 2019

NPA Patient safety

The dedicated NPA webpage for all resources, updates and reports related to patient safety

MHRA alerts and recalls for drugs and medical devices

MHRA webpage for all published alerts and recalls for drugs and medical devices

MHRA CAS alerts

The MHRA Central Alerting System